| Composition | Ursodeoxycholic Acid – 300 mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10x1x10 |
| Packing | Blister |
UDICOP-300 is a scientifically formulated medication enriched with Ursodeoxycholic Acid 300 mg, a naturally occurring bile acid used for the management of various liver and biliary disorders. It is widely prescribed by hepatologists and gastroenterologists for the treatment of cholesterol gallstones, primary biliary cholangitis, fatty liver, and other chronic hepatic conditions.
This medicine acts by reducing cholesterol saturation in bile, enhancing bile flow, and protecting liver cells (hepatocytes) from toxin-induced damage. By improving overall bile composition, UDICOP-300 restores the natural functioning of the liver and digestive system.
Ursodeoxycholic Acid (UDCA) is a secondary bile acid naturally present in small amounts in the human body. It replaces toxic bile acids in the liver and reduces their damaging effects. UDCA enhances the elimination of cholesterol from the body, thereby helping to dissolve gallstones and alleviate bile flow obstruction.
As an antioxidant and cytoprotective compound, UDCA prevents inflammation and fibrosis of liver tissues. Its strong clinical track record makes UDICOP-300 one of the most trusted liver care formulations available.
UDICOP-300 works at multiple levels to ensure complete liver and bile duct protection:
Cholesterol Dissolution:
Reduces cholesterol absorption from the intestine and promotes cholesterol solubilization in bile, helping dissolve small, non-calcified gallstones.
Cytoprotective Effect:
Protects hepatocyte membranes from damage caused by toxic bile acids and free radicals.
Enhanced Bile Flow (Choleretic Action):
Stimulates bile secretion and flow from the liver into the intestine, preventing bile stagnation (cholestasis).
Immunomodulatory Effect:
Regulates immune-mediated liver damage, particularly in autoimmune diseases such as primary biliary cholangitis (PBC).
Anti-Apoptotic Property:
Prevents premature death of liver cells and promotes hepatic regeneration.
UDICOP-300 (Ursodeoxycholic Acid 300 mg) is indicated in the treatment and management of:
Cholesterol Gallstones – Dissolution of small, non-calcified gallstones in patients unsuitable for surgery.
Primary Biliary Cholangitis (PBC) – First-line therapy for chronic cholestatic liver diseases.
Fatty Liver Disease (NAFLD / NASH) – Helps improve liver enzymes and lipid metabolism.
Chronic Hepatitis and Drug-Induced Liver Injury – Provides liver protection and aids in recovery.
Biliary Dyspepsia and Bile Reflux Gastritis – Reduces bile acid-induced irritation in the stomach.
Cystic Fibrosis-Related Liver Disease – Supports bile flow and minimizes hepatic damage.
Protects and Regenerates Liver Cells: Prevents hepatocyte injury from toxic bile acids and oxidative stress.
Dissolves Cholesterol Gallstones Naturally: Gradually breaks down stones without surgical intervention.
Improves Bile Secretion and Flow: Aids in better digestion and elimination of cholesterol.
Regulates Lipid Profile: Lowers harmful cholesterol and improves overall liver lipid metabolism.
Enhances Liver Enzyme Levels: Regular therapy normalizes SGPT, SGOT, and ALP values.
Reduces Fatty Liver and Inflammation: Improves hepatic function in NAFLD/NASH patients.
UDICOP-300 is well tolerated, but mild side effects may occur in rare cases:
Diarrhea or loose stools
Nausea or vomiting
Abdominal discomfort
Skin rash or itching
Temporary elevation of liver enzymes
If these effects persist or worsen, consult your healthcare provider immediately.
Medical Supervision Required: Always use UDICOP-300 under professional guidance.
Pregnancy and Lactation: Use only when clearly needed and prescribed.
Regular Monitoring: Liver function tests (LFTs) and ultrasound scans are advised during long-term use.
Avoid Alcohol: Alcohol can increase liver stress and reduce medicine efficacy.
Drug Interactions: Avoid concurrent use with cholestyramine, cyclosporine, or estrogen-containing contraceptives unless directed by a physician.
Contains pharma-grade Ursodeoxycholic Acid 300 mg for high potency.
Manufactured under GMP, WHO, and ISO-certified standards.
Clinically backed for effective gallstone dissolution and liver detoxification.
Safe for long-term management of chronic liver diseases.
Provides enhanced bile flow, lipid regulation, and cell protection in one formulation.
Store below 25°C, away from direct sunlight and moisture.
Keep in a cool, dry place and out of reach of children.
Do not freeze or expose to excessive heat.
Q1. Can UDICOP-300 be used for fatty liver?
Yes. Ursodeoxycholic Acid supports liver detoxification, reduces inflammation, and improves liver enzyme balance in fatty liver conditions.
Q2. How long does it take to dissolve gallstones with UDICOP-300?
It may take 6 months to 2 years, depending on stone size and composition. Regular medical evaluation is essential.
Q3. Can I take UDICOP-300 with other liver supplements?
Consult your doctor before combining it with other hepatoprotective or lipid-lowering agents to avoid interactions.
Q4. Is UDICOP-300 safe for long-term use?
Yes. When taken under medical supervision, UDICOP-300 is safe and effective for prolonged therapy.
UDICOP-300 (Ursodeoxycholic Acid 300 mg) is a powerful, high-strength hepatoprotective formulation that effectively supports liver health, promotes bile secretion, and dissolves cholesterol gallstones naturally. Its multifaceted action on bile acid balance, cholesterol metabolism, and liver cell protection makes it an essential therapy for patients with chronic liver or biliary diseases.
Regular, physician-guided use of UDICOP-300 helps restore liver function, improve digestion, and maintain long-term hepatic wellness.
